A randomized trial of pamrevlumab in patients with COVID-19 pneumonia

Respirology. 2023 Oct;28(10):954-957. doi: 10.1111/resp.14575. Epub 2023 Aug 21.
No abstract available

Keywords: COVID-19; interstitial lung disease; lung fibrosis; pulmonary fibrosis.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • COVID-19*
  • Humans

Substances

  • pamrevlumab
  • Antibodies, Monoclonal, Humanized

Associated data

  • ClinicalTrials.gov/NCT05262309